Revolutionizing Pathogenic Viral Immunosurveillance
Athari Bio is reshaping the landscape of health technology by advancing the way viral infections are detected, and how vaccines and therapeutic responses are evaluated. Our groundbreaking technology propels us to the forefront of global health innovation, enabling highly effective immunosurveillance and vaccine development for the betterment of public health.
Our goal is to revolutionize pathogenic viral immunosurveillance by leveraging a pioneering hybrid alphavirus-SARS-CoV-2 pseudovirus system, additional platform examples include SARS-CoV-2, RSV, Influenza, Dengue and more.
The Value of Change
Our unique approach to Pathogenic Viral Immunosurveillance provides truly transformative outcomes:
- Precision Tracking: We employ advanced algorithms and real-time data analytics to track disease spread and replication with unprecedented accuracy, supported by peer-reviewed research and clinical validations.
- Real-Time Surveillance: Our global network of technology integrations with leading health institutions allows for immediate identification and monitoring of immunity hotspots.
- Flexibility: We continuously evolve our technology to meet the dynamic challenges of emerging infectious diseases, incorporating the latest biotechnological innovations and AI-driven predictive modeling.
Key Scientific Advantages
We arm researchers and healthcare providers with cutting-edge tools:
- Rapid Detection: Deliver accurate diagnostic results within 6 hours, proven through rigorous scientific testing and endorsed by international health authorities.
- Safe Variant-Specific Quantitative Results: Our state-of-the-art, non-replicating assays are safely conducted in BSL-2 facilities, minimizing risk while maximizing reliability.
- 100 uL Sample Collection: Our proprietary bladeless microneedle array simplifies the collection process, making it less invasive and more accessible—a feature that has garnered acclaim from medical professionals worldwide.
Global Impact
Our pathogenic immunosurveillance solutions deliver lasting positive impacts on global health:
- Swift Identification of Low-Immunity Hotspots: By quickly identifying areas at risk, our technology facilitates early intervention, dramatically reducing outbreak severity.
- Optimized Countermeasure Deployment: We tailor responses to the specific needs of affected regions, enhancing the efficacy of public health interventions.
- Protection of Communities: Our proactive measures have a proven track record of safeguarding at-risk populations across continents.
